ARCHIVES

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

October 25, 2002

PhRMA Offers Assistance For Part D “Doughnut Hole”

June 26, 2009

ASCO 2011 Award Winners

June 10, 2011

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

More Than 300 request RFP for New Community Oncology Program

May 25, 1979